| Symbol | ACONW |
|---|---|
| Name | ACLARION, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Specialities |
| Address | 8181 ARISTA PLACE,SUITE 100, BROOMFIELD, Colorado, 80021, United States |
| Telephone | +1 833 275 - 2266 |
| Fax | — |
| — | |
| Website | https://www.aclarion.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001635077 |
| Description | Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Additional info from NASDAQ: |
Director Williams Amanda M 🟢 acquired 5.9K shares of Aclarion, Inc. (ACON) at $2.73 Transaction Date: Aug 17, 2026 | Filing ID: 006576
Read moreGould Gregory A 🟢 acquired 10.0K shares of Aclarion, Inc. (ACON) at $2.45 Transaction Date: Aug 14, 2026 | Filing ID: 006545
Read moreDirector Bond Ryan 🟢 acquired 21.1K shares of Aclarion, Inc. (ACON) at $2.37 Transaction Date: Aug 13, 2026 | Filing ID: 006516
Read moreDirector Wesemann William 🟢 acquired 2.1K shares of Aclarion, Inc. (ACON) at $2.34 Transaction Date: Aug 13, 2026 | Filing ID: 006514
Read moreDirector Neal David K 🟢 acquired 7.5K shares of Aclarion, Inc. (ACON) at $2.40 Transaction Date: Aug 13, 2026 | Filing ID: 006513
Read moreDirector Ness Brent 🟢 acquired 5.2K shares of Aclarion, Inc. (ACON) at $2.31 Transaction Date: Aug 13, 2026 | Filing ID: 006512
Read moreAclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscans MR Spectroscopy (MRS) Scan Process
Read moreAclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Read moreAclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Read more